Back
DoorDash, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Buy
76
DASH
DoorDash, Inc.
Last Price:
$226.57
Seasonality Move:
11.45%
Sell
40
RAPT
Rapt Therapeutics, Inc.
Last Price:
$33.91
Seasonality Move:
-27.57%
Buy
76
DoorDash, Inc. (DASH)
is a Buy
Is DoorDash, Inc. a Buy, Sell or Hold?
-
The current DoorDash, Inc. [DASH] share price is $226.48. The Score for DASH is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
DASH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DASH Stock Price Chart
What is DoorDash, Inc.'s stock price today?
-
The DoorDash, Inc. share price today is $226.48The current trend is relatively stagnant and DASH is experiencing selling pressure, which indicates risk of future bearish movement.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.
DASH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.82 | Buy |
| Relative Strength Index (14 RSI): | 50.59 | Buy |
| Chaikin Money Flow: | -1672795 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (211.3 - 234.26) | Buy |
| Bollinger Bands (100): | (217.32 - 266.6) | Sell |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.53 | Buy |
| Relative Strength Index (14 RSI): | 51.15 | Buy |
| Chaikin Money Flow: | 79100 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.58 - 35.84) | Sell |
| Bollinger Bands (100): | (16.83 - 33.91) | Buy |
DASH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 231.68 | Sell |
| 20-day SMA: | 227.85 | Sell |
| 50-day SMA: | 224.21 | Buy |
| 200-day SMA: | 227.06 | Sell |
| 8-day EMA: | 229.55 | Sell |
| 20-day EMA: | 226.57 | Sell |
| 50-day EMA: | 225.48 | Buy |
| 200-day EMA: | 158.32 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35 | Sell |
| 20-day SMA: | 34.72 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 17.02 | Buy |
| 8-day EMA: | 31.84 | Buy |
| 20-day EMA: | 21.97 | Buy |
| 50-day EMA: | 11.45 | Buy |
| 200-day EMA: | 3.3 | Buy |
DoorDash, Inc. Earnings Growth & DASH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $2.08 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
DoorDash, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||